eNewsroom for: Sanovas Surgical Technologies

http://pressreleaseheadlines.com/wp-content/Cimy_User_Extra_Fields/Sanovas Surgical Technologies//sanovas.png

Sanovas Surgical Technologies Company Profile

Sanovas revolutionary Smart Catheter technologies will now afford doctors the tools to venture into areas of the anatomy where they have never been.

News from Sanovas Surgical Technologies:

Lung Cancer Authority Dr. Gordon H. Downie Warns that Existing Resources to Treat Peripheral Tumors are "Grossly Inadequate" as Medicare Coverage of Lung Cancer Screening for At-Risk Beneficiaries Goes into Effect

The U.S. healthcare system is about to be deluged with diagnoses of early-stage lung cancers. SAN RAFAEL, Calif., Feb. 10, 2015 /PRNewswire/ — Sanovas Inc., a Life Science company accelerating the development and commercialization of next-generation micro invasive diagnostics, devices a…

Sanovas Commercializes Its Breakthrough Device-Reprocessing Product Designed to Identify Poorly Cleaned Medical Devices that Could Trigger Infections

SAN RAFAEL, Calif., Jan. 26, 2015 /PRNewswire/ — In wake of recent headlines about cross contamination of patients by inadequately reprocessed medical devices (see story in USA Today), Sanovas Inc., a Life Science company accelerating the development and commercialization of next-generati…

Lung Cancer Authority Warns That Existing Resources to Treat Peripheral Tumors Are "Grossly Inadequate" as Medicare Coverage of Lung Cancer Screening for At-risk Beneficiaries Goes Into Effect in 2015

"The U.S. healthcare system is about to be deluged with diagnoses of early-stage lung cancers, and therefore we need to develop appropriate therapies for peripheral tumors, where the majority of lung cancers begin," said Gordon H. Downie, MD, PhD. SAN RAFAEL, Calif., Jan. 7, 2015 /PRNewswi…

Sanovas Receives Frost & Sullivan Award for Breakthrough Endoscopic Imaging Platform, MicroCam™

Frost & Sullivan says, 'The MicroCam platform possesses the potential not only to redefine the economics of endoscopy in North America, but also to expand access to minimally invasive surgery for billions of patients globally.' SAN RAFAEL, Calif., Dec. 1, 2014 /PRNewswire/ — Sa…

Sanovas Awarded Seminal Patent for Novel Radiation Oncology Drug/Device Platform

SAN RAFAEL, Calif., Oct. 14, 2014 /PRNewswire/ — Sanovas Inc., a Life Science company accelerating the development and commercialization of next-generation microinvasive diagnostics, devices and drug delivery technologies, announced today that US Patent No. 8,834,544 has issued to the…

Healthmark Industries Co. Launches Breakthrough Device-Reprocessing Product Featuring Next-Generation Endoscopic Imaging Technology: MicroCam™

Flexible Inspection Scope is initial product of Healthmark's OEM partnership with MicroCam, Inc. SAN RAFAEL, Calif., Sept. 22, 2014 /PRNewswire/ — Sanovas Inc., a Life Science company accelerating the development and commercialization of next-generation micro-invasive diagnost…

Sanovas Subsidiary Signs Industrial and Medical OEM Partnerships for Its Next-generation Endoscopic Imaging Technology: MicroCam™

SAN RAFAEL, Calif., May 27, 2014 /PRNewswire/ — Sanovas Inc., a Life Science company accelerating the development and commercialization of next-generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that its MicroCam Inc. subsidiary has signed…

Sanovas Expands Management Team

SAUSALITO, Calif., April 28, 2014 /PRNewswire/ — Sanovas Inc. (www.sanovas.com), a Life Sciences Accelerator developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has appointed five experienced exe…

Sanovas Relocating Its International Operations to World-Class "BioTech Ready" Facility in San Rafael, Calif., To Accommodate Its Explosive Growth

SAUSALITO, Calif., April 22, 2014 /PRNewswire/ — Sanovas Inc. (www.sanovas.com), a Life Sciences Accelerator developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that it is relocating its business opera…

Sanovas Fortifies Patent Estate for its "Smart Catheter" Portfolio: Resector Balloon System Patent Strengthens Vas Zeppelin™ Platform

SAUSALITO, Calif., April 18, 2014 /PRNewswire/ — Sanovas Inc. (www.sanovas.com), a Life Sciences Accelerator developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has been awarded U.S. Patent No. 8…

Sanovas Appoints Jeff Heer As Chief Operating Officer

SAUSALITO, Calif., April 14, 2014 /PRNewswire/ — Sanovas Inc., a Life Sciences Accelerator developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has appointed Jeff Heer to serve as Chief Operating Offi…

Sanovas CEO Larry Gerrans Featured at BayBio's 'Fundraising in Troubled Times'

SAUSALITO, Calif., Jan. 24, 2012 — Sanovas CEO Larry Gerrans will participate in a panel titled "Fundraising in Troubled Times" as part of BayBio's Life Sciences Series on Thursday, Jan. 26 at 8 a.m. in Palo Alto. The event will take place at the Silicon Valley offices of DLA Piper.…

Profiles with Terry Bradshaw to Feature Sanovas

CORAL SPRINGS, Fla., Nov. 21, 2011 — The Producers of Profiles with Terry Bradshaw are pleased to announce that Sanovas will be featured in an upcoming segment on topics, trends, and issues related to "Improving Clinical Outcomes through Technology" as part of the show's "…

Sanovas CEO Larry Gerrans Featured Speaker at AdvaMed 2011

Industry's leading medical device visionaries to highlight practical insights and key learnings at AdvaMed 2011 Entrepreneurship Boot Camp SAUSALITO, Calif., Sept. 22, 2011 — Sanovas Inc., a leading developer of minimally invasive technologies for the diagnosis and treatment of pulm…

Science, Government and Industry Converge in National Call to Action on Lung Cancer

SAUSALITO, Calif., Aug. 11, 2011 — The New England Journal of Medicine's recent publication of the landmark National Lung Screening Trial (NLST), along with two congressional initiatives and an industry report, beacon a much brighter future for Lung Cancer patients. Forty-three millio…